Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising technological advancements in fill finish manufacturing processes
3.2.1.2 Growth of biopharmaceutical industry
3.2.1.3 Rising adoption of prefilled syringes for parenteral dosage forms
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with isolators/restricted access barrier systems (RABS)
3.2.2.2 Stringent regulatory issues
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Consumables
5.2.1 Prefilled syringes (PFS)
5.2.1.1 Glass PFS
5.2.1.2 Plastic PFS
5.2.2 Vials
5.2.2.1 Glass vials
5.2.2.2 Plastic vials
5.2.3 Cartridges
5.2.4 Other consumables
5.3 Instruments
5.3.1 By type
5.3.1.1 Integrated systems
5.3.1.2 Standalone systems
5.3.2 By operation
5.3.2.1 Automated machines
5.3.2.2 Semi-automated & manual machines
Chapter 6 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Parenteral drug delivery
6.3 Biologics manufacturing
6.4 Personalized medicines
6.5 Other applications
Chapter 7 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Pharmaceutical and biopharmaceutical companies
7.3 Contract manufacturing organizations
7.4 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 Saudi Arabia
8.6.2 South Africa
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Boehringer Ingelheim
9.2 Baxter International Inc.
9.3 Catalent, Inc.
9.4 Eurofins Scientific S.E.
9.5 Fresenius SE & Co. KGaA
9.6 MabPlex International Co., Ltd.
9.7 Novartis AG
9.8 Recro Pharma, Inc.
9.9 Recipharm
9.10 Symbiosis Pharmaceuticals Pvt. Ltd.
